EP-104

N/A

Report date: 2025/11/14 13:58:57

Base Information

Drug NameEP-104
Drug Alias NameFluticasone propionate Microparticle Formulation Extended release (Eupraxia Pharmaceuticals);EP-104
ClassificationSmall molecules > Steroids
Mechanisms of ActionGlucocorticoid receptor agonistsCytosolic phospholipase A2 agonists
TargetsGlucocorticoid receptorCytosolic phospholipase A2
Therapy Area/IndicationsInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEupraxia Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesEupraxia Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsInflammation
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A